Bempedoic acid + Ezetimibe FDC Oral Tablet
1002FDC-058
Phase 2 small_molecule completed
Quick answer
Bempedoic acid + Ezetimibe FDC Oral Tablet for Diabetes is a Phase 2 program (small_molecule) at Esperion Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Esperion Therapeutics
- Indication
- Diabetes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed